Trial intelligence / Profile preview

Pain Management and Behavioral Outcomes in Patients With Dementia

NCT00012857Phase 2Completed

Sponsor
United States Department of Veterans Affairs
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in pain and agitation comparing Scheduled Acetaminophen with Scheduled Placebo (2 arms). Primary endpoints: Discomfort Scale Score at 4 weeks, Cohen-Mansfield Agitation Inventory Score at 4 weeks and 1 more. Status: completed.

02

Drugs

acetaminophen
03

Conditions

painagitation

Beyond the preview

Go deeper on NCT00012857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00012857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call